DOI QR코드

DOI QR Code

척-스트라우스증후군(eosinophilic granulomatosis with polyangiitis) 환자에서 성공적으로 수행한 심장이식 1예

Heart transplantation in a patient with eosinophilic granulomatosis with polyangiitis known as Churg-Strauss syndrome

  • 박소영 (울산대학교 의과대학 내과학교실) ;
  • 김태은 (울산대학교 의과대학 내과학교실) ;
  • 김효정 (울산대학교 의과대학 내과학교실) ;
  • 신보미 (울산대학교 의과대학 서울아산병원 알레르기 내과) ;
  • 박소영 (울산대학교 의과대학 서울아산병원 알레르기 내과) ;
  • 권혁수 (울산대학교 의과대학 서울아산병원 알레르기 내과) ;
  • 문희범 (울산대학교 의과대학 서울아산병원 알레르기 내과) ;
  • 조유숙 (울산대학교 의과대학 서울아산병원 알레르기 내과) ;
  • 김태범 (울산대학교 의과대학 서울아산병원 알레르기 내과)
  • Park, Soyoung (Department of Internal Medicine, University of Ulsan College of Medicine) ;
  • Kim, Taeeun (Department of Internal Medicine, University of Ulsan College of Medicine) ;
  • Kim, Hyo Jung (Department of Internal Medicine, University of Ulsan College of Medicine) ;
  • Shin, Bomi (Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, So Young (Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kwon, Hyouk-Soo (Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Moon, Hee-Bom (Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Cho, You Sook (Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Tae-Bum (Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine)
  • 발행 : 20150000

초록

Eosinophilic granulomatosis with polyangiitis (EGPA), also known as Churg-Strauss syndrome, is a rare systemic necrotizing vasculitis affecting small- to medium-sized vessels. EGPA is associated with severe asthma and eosinophilia. The most frequently involved organs are skin and peripheral nerves; however, EGPA may involve other organs, such as the gastrointestinal tract, kidney, and heart. Antineutrophil cytoplasm antibodies (ANCAs)-related abnormal immune reactions are known to be associated with EGPA, but only 30%-40% of patients have a positive marker of ANCA. ANCA-negative patients are at higher risk of cardiac involvement than ANCA-positive patients. Cardiac involvement is one of the leading causes of mortality and could be resistant to conventional treatment. Early treatment with steroid plus cyclophosphamide is important because it could give chances of restoration of cardiac function. For patients undergoing heart transplantation, we should consider the severity of cardiac disease and the presence of systemic diseases, including vasculitis. Here, we report a case of a 25-year-old EGPA patient with cardiac involvement who eventually received heart transplantation for progressive heart failure, although treated with systemic corticosteroid with cyclophosphamide. EGPA patients undergoing heart transplantion are rarely reported worldwide, and this is the first case report in Korea.

키워드